Patents by Inventor Nickki L. Parlet

Nickki L. Parlet has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Enteral nutritional product for patients undergoing radiation therapy and/or chemotherapy
    Patent number: 5547927
    Abstract: An enteral nutritional product has been formulated for persons who are currently undergoing radiation therapy and/or chemotherapy. The nutritional product has a protein system which includes a soy protein hydrolysate. The nutritional product is very low in folic acid, contains .beta.-carotene, and has a ratio of n-6 to n-3 fatty acids that is in the range of about 1.3:1 to 2.5:1.
    Type: Grant
    Filed: May 28, 1993
    Date of Patent: August 20, 1996
    Assignee: Abbott Laboratories
    Inventors: Frederick O. Cope, Normanella T. DeWille, Ernest W. Richards, Terrence B. Mazer, Bonnie C. Abbruzzese, Gregory A. Snowden, Nickki L. Parlet, Laura A. Pease
  • Method of providing enteral nutritional support for patients undergoing radiation therapy and/or chemotherapy
    Patent number: 5514656
    Abstract: A method of providing enteral nutritional support to a person who is currently undergoing chemotherapy and/or radiation therapy involves including in the person's diet an enteral nutritional product having a protein system which includes a soy protein hydrolysate. The nutritional product is very low in folic acid, contains .beta.-carotene, and has a ratio of n-6 to n-3 fatty acids that is in the range of about 1.3:1 to 2.5:1.
    Type: Grant
    Filed: May 28, 1993
    Date of Patent: May 7, 1996
    Assignee: Abbott Laboratories
    Inventors: Frederick O. Cope, Normanella T. DeWille, Ernest W. Richards, Terrence B. Mazer, Bonnie C. Abbruzzese, Gregory A. Snowden, Nickki L. Parlet, Laura A. Pease
  • Method for reducing insulin resistance in mammals
    Patent number: 5283260
    Abstract: A method for administering pyruvate is disclosed which comprises administering a therapeutically effective amount of a pyruvate precursor to a mammal in the form of pyruvamide or a pyruvyl-amino acid. The pyruvyl-amino acid is preferably selected from the group comprising pyruvyl-glycine, pyruvyl-alanine, pyruvyl-leucine, pyruvyl-valine, pyruvyl-isoleucine, pyruvylphenyl al anine, pyruvyl-proline and pyruvyl-sarcosine, and their amides and esters as well as their salts. Associated with the administration of a pyruvate precursor to a mammal in accordance with this invention are improved insulin resistance, lower fasting insulin levels, and reduced fat gain. Novel methods of synthesizing several pyruvate precursors are also disclosed.
    Type: Grant
    Filed: April 8, 1993
    Date of Patent: February 1, 1994
    Assignee: Abbott Laboratories
    Inventors: Robert H. Miller, Nickki L. Parlet, Kent L. Cipollo, Madhup K. Dhaon, John A. Houbion, Edwin O. Lundell
  • Method of administering pyruvate and methods of synthesizing pyruvate precursors
    Patent number: 5256697
    Abstract: A method for administering pyruvate is disclosed which comprises administering a therapeutically effective amount of a pyruvate precursor to a mammal in the form of pyruvamide or a pyruvyl-amino acid. The pyruvyl-amino acid is preferably selected from the group comprising pyruvyl-glycine, pyruvyl-alanine, pyruvyl-leucine, pyruvyl-valine, pyruvyl-isoleucine, pyruvyl-phenylalanine, pyruvyl-proline and pyruvyl-sarcosine, and their amides and esters as well as their salts. Associated with the administration of a pyruvate precursor to a mammal in accordance with this invention are improved insulin resistance, lower fasting insulin levels, and reduced fat gain. Novel methods of synthesizing several pyruvate precursors are also disclosed.
    Type: Grant
    Filed: April 16, 1992
    Date of Patent: October 26, 1993
    Assignee: Abbott Laboratories
    Inventors: Robert H. Miller, Nickki L. Parlet, Kent L. Cipollo, Madhup K. Dhaon, John A. Houbion, Edwin O. Lundell